Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
08/1996
08/22/1996WO1996017935A3 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
08/22/1996CA2212370A1 Inhibition of angiogenesis using interleukin-12
08/22/1996CA2211836A1 Indole derivatives with affinity for the cannabinoid receptor
08/22/1996CA2208073A1 Alpha-substituted hydrazides having calpain inhibitory activity
08/21/1996EP0726911A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
08/21/1996EP0726895A1 Pseudodipeptide product having an imidazole grouping and applications
08/21/1996EP0726773A1 Method for inhibiting angiogenesis using heparinase
08/21/1996EP0726769A1 Method and means for prevention of cataract
08/21/1996EP0614457B1 Leukotriene-b 4? derivatives, process for preparing the same and medicaments
08/21/1996EP0516691B1 Neuropeptide control of ocular growth
08/21/1996CN1129397A Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
08/21/1996CN1129102A Catechol diether compounds as inhibitors of TNF release
08/20/1996US5547968 Treatment of ocular hypertension with a synergistic combination
08/18/1996CA2168303A1 Azepinone compounds useful in the inhibition of ace and nep
08/15/1996WO1996024371A1 Multifunctional enzyme
08/15/1996WO1996024346A1 Deprenyl compounds for treatment of glaucoma
08/15/1996WO1996018391A3 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
08/15/1996WO1996011685A3 Use of indole derivatives for the treatment of various diseases
08/15/1996CA2212533A1 Multifunctional enzyme
08/15/1996CA2212412A1 Deprenyl compounds for treatment of glaucoma
08/14/1996EP0725643A1 Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents
08/14/1996EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
08/14/1996EP0670826A4 Fatty acid derivatives and pharmaceutical compositions containing them.
08/14/1996EP0618913B1 Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
08/14/1996EP0533828B1 Pgf 1-alcohols and their use as ocular hypotensives
08/13/1996US5545669 Anti-inflammatory compounds
08/13/1996US5545665 Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
08/13/1996US5545641 Methods of inhibiting physiological conditions associated with an excess of bradykinin
08/13/1996CA1338519C Antiglaucoma compositions containing combinations of sympathomimetic agents and beta-1 selective beta-blockers
08/08/1996WO1996023787A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/08/1996WO1996023512A1 Extracts of shark cartilage, process of production and uses thereof
08/08/1996WO1996023505A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
08/08/1996WO1996023498A1 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
08/08/1996WO1996023490A1 Formulations and methods for reducing skin irritation
08/08/1996CA2212127A1 Formulations and methods for reducing skin irritation
08/08/1996CA2211783A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
08/07/1996EP0724567A1 1,11-diesters of prostaglandin-f 2 alpha having a polar ester group at c-1
08/07/1996EP0724566A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
08/07/1996EP0724443A1 Methods and compositions for lowering intraocular pressure
08/07/1996EP0724425A1 New use of prostaglandins
08/07/1996CN1128264A Crystalline form of dihydro-2,3-benzodiazepine derivative
08/07/1996CN1128262A Substituted biphenyl isoxazole sulfonamides
08/06/1996US5543562 Non-hygroscopic monoammonium salts of phosphonic acids or phosphinic acids
08/06/1996US5543528 Useful as angiotensin ii antagonist
08/06/1996US5543434 Nasal administration of ketamine to manage pain
08/06/1996US5543420 Aldose reductase inhibitors; antidiabetic agents; prevention of accumulation of sorbitol and galactitol in mammalian tissue
08/06/1996US5543147 Antiinflammatory and wound healing acitivity
08/01/1996WO1996023068A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
08/01/1996WO1996023065A2 Inhibition of neovascularization using vegf-specific oligonucleotides
07/1996
07/31/1996EP0723958A1 Synthesis of substantially pure terfenadine derivatives
07/31/1996EP0723447A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
07/30/1996US5541229 Benzimidazoles and medicaments containing these compounds
07/30/1996US5541228 Melatonergic agents
07/30/1996US5541210 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 andrenoceptor agonists
07/30/1996US5541202 New leukotriene-B4 Antagonists and their use as pharmaceutical agents
07/30/1996US5541195 1-acylpiperidine compounds
07/30/1996US5540930 Nonagglomerating suspension
07/30/1996US5540918 Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
07/25/1996WO1996022095A2 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
07/24/1996EP0723015A1 Novel modified PF4 compositions and methods of use
07/24/1996EP0722928A1 Bicyclic-aromatic compounds with strong biologic activity, pharmaceutical and cosmetic compositions containing them and uses thereof
07/24/1996EP0722326A1 Highly sulfated maltooligosaccharides with heparin-like properties
07/23/1996US5538721 Stabilization of aminosteroids for topical ophthalmic and other applications
07/17/1996EP0721454A1 New pyrazole derivatives as angiotensin ii antagonist
07/17/1996EP0609289B1 Imidazole derivatives and pharmaceutical compositions containing the same
07/17/1996CN1126995A Antiallergic imidazoazepines
07/17/1996CN1126727A 11,21-bisphenyl-19-norpregnane derivatives
07/11/1996WO1996020930A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
07/11/1996WO1996020918A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases
07/11/1996WO1996020914A1 Tricyclic retinoids, methods for their production and use
07/11/1996WO1996020913A1 Novel trienoic retinoid compounds and methods
07/11/1996WO1996020708A1 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
07/11/1996CA2209134A1 Tricyclic retinoids, methods for their production and use
07/11/1996CA2208844A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
07/11/1996CA2208679A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases
07/10/1996EP0619818B1 Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
07/09/1996US5534539 Antitumor agents
07/09/1996US5534528 Thiadiazolyl tetrhydrpyridines for treating glaucoma
07/04/1996WO1996020217A1 Monoclonal antibody
07/04/1996WO1996020187A2 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
07/04/1996DE4447599A1 Use of racemic or enantiomeric alpha liponic acid and derivs
07/03/1996EP0719770A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition
07/03/1996EP0719767A1 Succinamic acid compound, process for producing the same, and use thereof
07/03/1996EP0719764A1 3-Phenylisoquinolin-1 (2H)-one derivatives as GABA receptor ligands
07/03/1996EP0719331A1 Eotaxin = eosinophil chemotactic cytokine
07/03/1996EP0719274A1 Method for dosing therapeutic compounds
07/03/1996EP0719273A1 Nucleotide analogs
07/03/1996EP0719156A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
07/03/1996CN1032204C Process for preparing acetylenes disubstituted with phenyl group and heterobicyclic group having retinoid like activity
07/02/1996US5532276 Angiotensin ii antagonists, hypotensive
07/02/1996US5532237 Intraocular for treatment of glaucoma
07/02/1996US5530966 Protective garment for baseball umpires having an inner cushioned layer and an outer layer of interconnected plates
06/1996
06/30/1996CA2166234A1 3-phenylisoquinol-1(2h)-one derivatives, their preparation and their therapeutic application
06/29/1996CA2166168A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition
06/26/1996EP0718286A1 3-Alkoxybenzylpiperidine derivatives as melatonergic agents
06/26/1996EP0717998A1 Use of substance P antagonist for the treatment of pruritis, eye or eyelid pain or disesthesies
06/26/1996EP0717732A1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use
06/26/1996EP0717624A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
06/26/1996EP0717620A1 Substituted 2-aminotetralins
06/25/1996US5530136 Process for the preparation of pilocarpine derivatives from a 5-formyl-imidazole derivative
1 ... 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 ... 531